Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations


Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Tuesday, as follows:

AmerisourceBergen Corp. (NYSE:ABC) was reiterated as Buy and the price target was raised to 115 at Argus.

Bluebird Bio Inc. (NASDAQ:BLUE) was started with an Outperform rating at William Blair. Shares trade in a 52-wk range of 74.45 – 222.03.

Cactus Inc. (NYSE:WHD) has an Overweight rating and a 31 price target at Barclays. It was started as Overweight with a 32 target price at JPMorgan, and Credit Suisse started it as Outperform with a 31 price target.

Evolus Inc. (NASDAQ:EOLS) was started with a Buy rating and assigned a 24 price target at SunTrust Robinson Humphrey. Mizuho started it with a Buy rating and assigned a 21 price target, while JMP Securities started it as Market Perform with a 20 price target.

Groupon Inc. (NASDAQ:GRPN) was raised to Equal Weight from Underweight with a 4.40 price target at Morgan Stanley.

H&R Block Inc. (NYSE:HRB) was raised to Buy from Neutral at Northcoast Capital. The stock trades in a 52-wk range of 20.50 – 31.80.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :